STAS
NKTR icon

Strong Tower Advisory Services’s Nektar Therapeutics NKTR Stock Holding History

Strong Tower Advisory Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-710
Closed -$34K – 98
2022
Q3 		$34K Sell
710
-80
-10% -$4.76K 0.02% 96
2022
Q2 		$45K Sell
790
-447
-36% -$28.2K 0.02% 102
2022
Q1 		$100K Sell
1,237
-28,955
-96% -$4.29M 0.05% 104
2021
Q4 		$6.12M Buy
30,192
+3,194
+12% +$693K 3.26% 7
2021
Q3 		$6.91M Buy
+26,998
New +$6.49M 4.02% 6

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Strong Tower Advisory Services's NKTR Position: Q4 2022 in Review

Strong Tower Advisory Services sold out of Nektar Therapeutics (NKTR) in Q4 2022, closing a stake of 710 shares — an estimated $34K sold.

Strong Tower Advisory Services first reported a position in NKTR in Q3 2021 and held it in 5 quarters. The position peaked at $6.91M in Q3 2021. 214 funds tracked by Wall St. Rank hold NKTR as of Q4 2022.

  • Strong Tower Advisory Services reported no remaining Nektar Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Strong Tower Advisory Services sold 710 Nektar Therapeutics shares in Q4 2022, an estimated $34K.
  • Strong Tower Advisory Services first reported a position in Nektar Therapeutics in Q3 2021 and held it in 5 quarters.
  • Strong Tower Advisory Services's Nektar Therapeutics position peaked at $6.91M in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2022.

Based on Strong Tower Advisory Services's 13F filing for Q4 2022, filed 20 Jan 2023.